1-855-378-42281-855-378-4228
One of the outpatient rehabilitation options for individuals in Lafayette who are struggling with opioid abuse and addiction is called opioid maintenance therapy. Licensed facilities and doctors are authorized to administer certain medications to opioid addicted individuals, many of which are opioids also and are habit forming. With low enough doses the individual doesn't experience high feelings but also doesn't experience intense cravings and isn't experiencing opioid withdrawal. Methadone is the first med tried for this purpose, but there are other options currently to pick from.
Methadone is an opioid and can be taken at an out-patient clinic licensed to administer the med, that is taken on a daily basis as a pill or liquid. The price of the drug is approximately $150 monthly. Buprenorphine is also an opiate based med, and is a pill often taken one day on, one day off. But different from Methadone that can only be administered in highly structured clinics, Buprenorphine can be prescribed and administered in doctor's offices. The monthly cost of buprenorphine is approximately $300 monthly for the generic version of the med. There is also a version of buprenorphine containing the drug naloxone, that is a drug which reverses the effects of opiates. An individual consuming this version of the drug, also known as Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It too is taken daily, and is priced about $450 /month. Naltrexone is another med taken in opioid maintenance therapy, but unlike the other medications mentioned here it is an opiate blocker and isn't an opioid. There is an option to take this drug as a monthly shot, and that is called Vivitrol. As an opioid blocker, the drug prevents an individual from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 /month.
For All Drug and Alcohol Treatment Programs In Lafayette, Click Here.
